Estimation of Serum Vitamin D2, Growth Hormone, Alkaline Phosphatase and Calcium Phosphate Product in Patients with End Stage Renal Disease

INTRODUCTION
 The chronic kidney disease (CKD) patient's calcium phosphate product, alkaline phosphatase (ALP), vitamin-D2 and human growth hormone (hGH) are altered under haemodialysis. This study aimed to evaluate these biochemical variables in conjunction with haemoglobin blood pressure find out their association End Stage Renal Disease (ESRD) patients.
 MATERIAL AND METHODS
 cross-sectional comprised of 104 patients ESRD undergoing estimated glomerular filtration rate (eGFR) was calculated by Cockcroft-Gault (CG) equation calcium, phosphorus, ALP were measured fully automated analyzer whereas hGH sandwich competitive enzyme linked immune sorbent assay (ELISA) techniques.
 RESULTS
 mean age 53.12 ±16.37 years comprising 68% male. hypovitaminosis D 57.7% deficiency 23.1% insufficiency states 22.1%. product found be increased only 39.9% cases. level observed 64.4% There statistically significant between Hb status (p=0.03). difference sodium Ca×P cases hypertension (p=0.03 p=0.01) respectively. Moreover, the eGFR (p=0.0001and respectively.
 CONCLUSION
 Increased hypovitaminosis-D very common dialysis less prevalence increment. anaemia can pre-existing condition which cumbersome control if not monitor patients.